How Private Equity Shaped the Abortion Pill




The Takeaway show

Summary: <p><a href="https://www.fda.gov/drugs/postmarket-drug-safety-information-patients-and-providers/information-about-mifepristone-medical-termination-pregnancy-through-ten-weeks-gestation">Medication abortions</a><span> </span>are the<span> </span><a href="https://www.guttmacher.org/article/2022/02/medication-abortion-now-accounts-more-half-all-us-abortions">most common method</a><span> </span>in the U.S. for terminating a pregnancy, and the<span> </span><a href="https://www.reuters.com/world/us/us-fda-says-abortion-pills-can-be-sold-retail-pharmacies-new-york-times-reports-2023-01-03/">FDA recently moved<span> </span></a>to allow retail pharmacies to sell the abortion pill. So despite<span> </span><a href="https://www.washingtonpost.com/politics/2023/02/05/abortion-pills-texas-lawsuit/">continuing attacks<span> </span></a>on abortion rights and access, t<span>he abortion pill has been an incredibly lucrative gamble for a </span>secretive group of<span> </span><a href="https://www.motherjones.com/politics/2022/05/private-equity-apollo-blackstone-kkr-carlyle-carried-interest-loophole/">private equity investors</a><span> </span>— who are now battling each other for control of its future.</p> <p>We speak with Mother Jones reporter,<span> </span><a href="https://twitter.com/h_lev?lang=en">Hannah Levintova</a>. Her new story is<span> </span><a href="https://www.motherjones.com/politics/2023/01/abortion-pill-mifepristone-mifeprex-roe-dobbs-private-equity/">"The Abortion Pill’s Secret Money Men." </a></p>